ED Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price is stretched/overbought (RSI_6 ~80) and sitting near resistance, which reduces near-term upside for an impatient entry.", "Momentum is positive (bullish MAs and expanding MACD), but the setup favors a pullback after a run rather than chasing here.", "Options positioning is call-leaning (bullish sentiment), yet implied volatility is elevated (IV percentile ~73), suggesting optimism is already priced in.", "With earnings coming on 2026-02-19 (after hours) and no fresh positive news catalysts, risk/reward looks skewed toward a near-term dip rather than immediate upside."]
["Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, indicating a strong uptrend.", "Momentum: MACD histogram +0.413 and expanding, confirming upside momentum is still in place.", "Overbought: RSI_6 at ~80.26 signals the rally is extended and prone to short-term mean reversion.", "Levels: Pivot 105.50; immediate resistance already being tested around R1 108.68 with next resistance at R2 110.64. Support sits near 105.50 then 102.32.", "Pattern-based short-term bias: Similar-pattern stats imply a 50% chance of -2.11% next day and -4.42% next week, consistent with pullback risk after an overbought push.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Hedge fund activity: "Hedge Funds are Buying" with buying amount up ~108% over the last quarter (institutional support).", "Regulatory visibility: NYPSC approval of the 2026\u20132028 rate plan improves near-term earnings visibility (reduces uncertainty).", "Fundamental momentum (latest reported quarter): solid YoY revenue/EPS/net income growth in 2025/Q3.", "Defensive utility profile can benefit if broader markets remain soft (S&P 500 down on the day)."]
["Technical overheating: RSI overbought near resistance (R1/R2), increasing odds of a quick pullback.", "Wall Street skepticism: multiple Underperform/Underweight stances cite limited catalysts and NY affordability/political risk as constraints on re-rating.", "Event risk ahead: QDEC 2025 earnings on 2026-02-19 after hours can introduce downside volatility if guidance/capex/regulatory commentary disappoints.", "No supportive news flow in the last week to justify chasing the recent move higher."]
["Latest quarter provided: 2025/Q3.", "Revenue: $4.53B, +10.70% YoY (top-line acceleration).", "Net income: $688M, +17.01% YoY (profit growth outpacing revenue).", "EPS: 1.90, +12.43% YoY (solid earnings growth).", "Gross margin: 63.71%, -3.62% YoY (margin compression is a watch item)."]
["Recent trend: multiple price targets were raised in January, but ratings largely stayed Neutral/Hold/Sector Perform, with several Underperform/Underweight reiterations.", "Notable calls: UBS to $112 (Neutral); RBC to $118 (Sector Perform); TD Cowen initiated Hold at $105.", "Bearish/underweight views: BofA Underperform to $99; Morgan Stanley Underweight to $96; Barclays raised PT to $166 but kept Underweight (rating remains negative despite higher target).", "Wall Street pros: improved regulatory visibility and defensive profile; model updates/capex clarity supporting incremental PT lifts.", "Wall Street cons: limited incremental catalysts beyond 5\u20137% long-term EPS growth guidance, NY affordability/political constraints, and risk/reward seen as worse than peers at current levels."]
